Page last updated: 2024-08-17

5-methylsalicylic acid and protocatechuic acid

5-methylsalicylic acid has been researched along with protocatechuic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT1
Ban, HS; Ishihara, K; Nabeyama, W; Nakamura, H; Wada, H1
Brear, P; De Fusco, C; Georgiou, KH; Hyvönen, M; Iegre, J; Sore, HF; Spring, DR1

Other Studies

3 other study(ies) available for 5-methylsalicylic acid and protocatechuic acid

ArticleYear
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
    Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2

    Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc

2011
Discovery of (2-aminophenyl)methanol as a new molecular chaperone that rescues the localization of P123S mutant pendrin stably expressed in HEK293 cells.
    Bioorganic & medicinal chemistry, 2017, 05-01, Volume: 25, Issue:9

    Topics: Amino Acid Substitution; Benzyl Alcohols; Cell Membrane; Goiter, Nodular; Hearing Loss, Sensorineural; HEK293 Cells; Humans; Membrane Transport Proteins; Microscopy, Fluorescence; Salicylates; Sulfate Transporters

2017
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
    Bioorganic & medicinal chemistry, 2017, 07-01, Volume: 25, Issue:13

    Topics: Binding Sites; Biphenyl Compounds; Casein Kinase II; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship

2017